Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Shock | Case report

An unusual case of dengue shock syndrome complicated by ilio-femoral deep vein thrombosis; a case report

Authors: K. M. I. U. Ranasinghe, D. Dissanayaka, K. Thirumavalavan, M. Seneviratne

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Dengue fever is a hemorrhagic fever caused by flaviviruses. Hemorrhagic manifestations are well known to be associated with dengue fever, though the thrombotic events are only seldom reported. Underlying pathophysiology of thrombotic events is multifactorial and the management is challenging due to associated thrombocytopenia and bleeding tendency. We report a case of dengue shock syndrome with severe thrombocytopenia complicated by ilio-femoral deep vein thrombosis.

Case presentation

A 16 year old boy presented with dengue fever. He had dengue shock syndrome after entering the critical phase on the fifth day of the illness. With the recovery from the critical phase he developed deep vein thrombosis involving right external iliac, common femoral and superficial femoral veins. There were no provocative factors other than dengue fever itself. His platelet count was 12,000/μl at the time of diagnosis with deep vein thrombosis. Anticoagulation was started with intravenous unfractionated heparin 500 IU/hour while closely being observed for bleeding complications. 1000 IU/hour dose was commenced with the recovery of the platelet count above 50,000/μl. Thrombophilia screening was negative and he was discharged on warfarin. Venous duplex done after 6 weeks showed normal lower limb venous flow and warfarin was omitted after three months.

Conclusions

With dengue fever, complications like deep vein thrombosis can be easily missed given its rarity and that the major concern is on hemorrhagic complications. Management is challenging due to associated thrombocytopenia and hemorrhagic complications.
Literature
1.
go back to reference World Health O. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization; 2009. p. 14–15. World Health O. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization; 2009. p. 14–15.
4.
go back to reference Biswas AP, Devgan G, Singla V, Murthy P, Dhariwal P, Sen A, Baruah PKK. Indian national guidelines for clinical management of dengue fever. 2015;113:196–206. Biswas AP, Devgan G, Singla V, Murthy P, Dhariwal P, Sen A, Baruah PKK. Indian national guidelines for clinical management of dengue fever. 2015;113:196–206.
6.
go back to reference Agarwal A, Sharma S, Airun M. Life-threatening thrombo-embolic events in a case of dengue hemorrhagic fever. J Assoc Physicians India. 2016;64(8):87–89. Agarwal A, Sharma S, Airun M. Life-threatening thrombo-embolic events in a case of dengue hemorrhagic fever. J Assoc Physicians India. 2016;64(8):87–89.
9.
go back to reference Dissanayake NUA. Life threatening thromboembolic event following Dengue hemorrhagic fever. Sri Lankan J Cardiol. 2019;1(2):69–72. Dissanayake NUA. Life threatening thromboembolic event following Dengue hemorrhagic fever. Sri Lankan J Cardiol. 2019;1(2):69–72.
10.
go back to reference Tilara M, Shah AN, Negi S, Dadhania J. A case of cerebral venous thrombosis in the patient with dengue. Int J Sci Res Publ. 2014;4(8):1–1. Tilara M, Shah AN, Negi S, Dadhania J. A case of cerebral venous thrombosis in the patient with dengue. Int J Sci Res Publ. 2014;4(8):1–1.
14.
go back to reference Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ, Levin M. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35(3):277–85. https://doi.org/10.1086/341410.CrossRefPubMed Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ, Levin M. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35(3):277–85. https://​doi.​org/​10.​1086/​341410.CrossRefPubMed
18.
go back to reference Sellahewa KH. Haematological disturbances in dengue Haemorrhagic fever-its pathogenesis and management perspectives. J Hematol Oncol Res. 2015;1(3):15.CrossRef Sellahewa KH. Haematological disturbances in dengue Haemorrhagic fever-its pathogenesis and management perspectives. J Hematol Oncol Res. 2015;1(3):15.CrossRef
19.
go back to reference Djamiatun K, Van der Ven AJ, de Groot PG, Faradz SM, Hapsari D, Dolmans WM, Sebastian S, Fijnheer R, de Mast Q. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis. 2012;6(5):e1628. doi.org/https://doi.org/10.1371/journal.pntd.0001628. Djamiatun K, Van der Ven AJ, de Groot PG, Faradz SM, Hapsari D, Dolmans WM, Sebastian S, Fijnheer R, de Mast Q. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis. 2012;6(5):e1628. doi.org/https://​doi.​org/​10.​1371/​journal.​pntd.​0001628.
Metadata
Title
An unusual case of dengue shock syndrome complicated by ilio-femoral deep vein thrombosis; a case report
Authors
K. M. I. U. Ranasinghe
D. Dissanayaka
K. Thirumavalavan
M. Seneviratne
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05062-y

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue